跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TS-6
首页
药物
TS-6
TS-6
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
T. cruzi-derived neurotrophic agents and methods of use therefor
申请人: TUFTS COLLEGE
优先权: 2000
US
5 件公开
Method for manufacturing a high strength steel sheet and sheet obtained
申请人: ARCELORMITTAL
优先权: 2014
CN
US
3 件公开
PROCESS FOR PREPARING A GRANULAR MATERIAL
申请人: BASF SE
优先权: 2023
CN
WO
2 件公开
2,5-cis-bisubstituted pyrrolidine derivative, its synthesizing method and usage
申请人: SHANGHAI INST ORGANIC CHEM
优先权: 2002
CN
Newly identified cholinephosphotransferases and ethanolaminephosphotransferases
申请人: UNIV UTRECHT HOLDING BV
优先权: 2003
US
Thymidylate synthase polymorphisms for use in screening for cancer susceptibility
申请人: MANDOLA MICHAEL
优先权: 2005
US
Antisense oligonucleotides against thymidylate synthase
申请人: SARISSA INC
优先权: 2005
US
BIOLOGICAL MATERIALS AND USES THEREOF
申请人: PHOTOBIOTICS LTD
优先权: 2005
US
T. Cruzi-derived neurotrophic agents and methods of use therefor
申请人: UNIV TUFTS
优先权: 2007
US
Synthetic method of 6-oxo-2-azaspiro[3,3]heptane-2-t-butyl carboxylate
申请人: NANJING YAOSHI PHARMACEUTICAL RES DEV CO LTD
优先权: 2011
CN
第 1 / 3 页
上一页
下一页
药物
反馈